Published in Endokrynol Pol on February 12, 1982
Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation. Am J Cardiol (1997) 1.78
Adrenocortical carcinoma. A clinical study and treatment results of 52 patients. Cancer (1995) 0.98
Decreased plasma dehydroepiandrosterone sulfate and dihydrotestosterone concentrations in young men after myocardial infarction. Atherosclerosis (1989) 0.86
Leptin and ghrelin concentrations and weight loss in Parkinson's disease. Acta Neurol Scand (2009) 0.85
The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome. J Endocrinol Invest (1991) 0.83
[Radioimmunoassay of total serum thyroxine and triiodothyronine]. Endokrynol Pol (1977) 0.81
Natural killer cell activity and sex hormone levels in mastopathy. Gynecol Endocrinol (1997) 0.79
Does leptin modulate immune and endocrine response in the time of LPS-induced acute inflammation? Neuro Endocrinol Lett (2001) 0.79
The role of sex hormones in the mechanism of inhibited LH release in female patients with anorexia nervosa. Acta Endocrinol (Copenh) (1982) 0.78
Hyperinsulinaemia and decreased plasma levels of dehydroepiandrosterone sulfate in premenopausal women with coronary heart disease. J Intern Med (1995) 0.78
[Obstructive sleep apnea and risk factors for coronary artery disease]. Pneumonol Alergol Pol (2000) 0.78
Plasma immunoreactive atrial natriuretic factor is inhibited by selective blockade of alpha 2-adrenergic receptors in conscious Sprague-Dawley rats. Neurosci Lett (1987) 0.78
Correlation between 21 amino acid endothelin, intrafollicular steroids and follicle size in stimulated cycles. Hum Reprod (1999) 0.77
Comment of long-acting lanreotide inducing clinical and biochemical remission of acromegaly caused by disseminated GHRH secreting carcinoid. J Clin Endocrinol Metab (1999) 0.77
Enhanced testosterone in female patients with anorexia nervosa: its normalization after weight gain. Acta Endocrinol (Copenh) (1979) 0.77
Plasma immunoreactive atrial natriuretic factor (IR-ANF) increases markedly after alpha 2-adrenergic stimulation with clonidine in normally-hydrated rats. Biochem Biophys Res Commun (1987) 0.77
Cytostatics for acromegaly. Marked improvement in a patient with an invasive pituitary tumour. Acta Endocrinol (Copenh) (1987) 0.77
Kinetic properties of human muscle pyruvate kinase. Mol Cell Biochem (1982) 0.77
Antidiuretic effect of sulfonylureas in idiopathic diabetes insipidus. Helv Med Acta (1969) 0.76
The effect of naloxone on ATCH and beta-endorphin in patients with Cushing's disease. Acta Endocrinol (Copenh) (1985) 0.76
Enhancement of plasma corticotropin-releasing hormone in pregnancy-induced hypertension. Acta Endocrinol (Copenh) (1990) 0.76
Stress-induced injury of pig myocardium is accompanied by increased lipid peroxidation and depletion of mitochondrial ATP. Exp Pathol (1991) 0.76
Ultrastructural changes in the central and peripheral nervous system in the rat with experimental allergic encephalomyelitis. Folia Neuropathol (1998) 0.76
The effect of some dithiocarbamic acids on dopamine-beta-hydroxylase and catecholamines level in rat's brain. Pol J Pharmacol Pharm (1976) 0.76
The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion. J Clin Endocrinol Metab (1984) 0.76
Radioimmunological determination of exogenous corticotropin-releasing hormone (CRH) and growth hormone-releasing hormone (GHRH): plasma half-life of CRH and GHRH. Endokrynol Pol (1989) 0.76
The effect of oral ethanol ingestion on the diurnal neurotensin secretion in man. Endokrynol Pol (1992) 0.75
[Mechanism of hormonal action mediated by cyclic 3', 5' AMP]. Pol Arch Med Wewn (1975) 0.75
Effects of cyproheptadine and metyrapone on ACTH and aldosterone concentrations in patients with Cushing's disease: a preliminary report. Mater Med Pol (1982) 0.75
Evidence for alpha-adrenergic receptors mediated TSH release in men. Acta Endocrinol (Copenh) (1980) 0.75
[Treatment of the malignant phase of infiltrative-edematous exophthalmos in Graves-Basedow disease]. Pol Tyg Lek (1985) 0.75
Radioimmunological determination of beta-endorphin-like substance in human blood plasma and urine. Endokrynol Pol (1986) 0.75
Conversion of 3H-testosterone to dihydrotestosterone in human hypertrophic prostatic tissue. Nuklearmedizin (1979) 0.75
[Solid phase radioimmunoassay for human growth hormone]. Endokrynol Pol (1978) 0.75
[Effect of metoclopramide and acth on aldosterone secretion in patients with insufficiency of the anterior pituitary gland]. Pol Arch Med Wewn (1985) 0.75
[Long-term inhibition of growth hormone secretion after alcohol intake. Disorders of physiological diurnal rhythm]. Pol Tyg Lek (1985) 0.75
[Hypogonadotropinemia in women with Cushing's syndrome]. Endokrynol Pol (1980) 0.75
Increased plasma VIP concentration in patients with prolactinoma. Endokrynol Pol (1992) 0.75
[Cushing's syndrome: metyrapone therapy as a preparation for selective trans-sphenoidal adenomectomy]. Endokrynol Pol (1982) 0.75
[Therapeutic classification of diabetes insipidus resulting from vasopressin deficiency into sensitive and resistant to chlorpropamide treatment]. Pol Arch Med Wewn (1971) 0.75
[Intraocular pressure in patients with infiltrative-edematous exophthalmos in Graves' disease treated with prednisone]. Klin Oczna (1990) 0.75
TRH-induced growth hormone release in insulin-dependent diabetes mellitus. Horm Metab Res (1984) 0.75
The effect of naloxone on the secretion of pituitary hormones in patients with acromegaly, microprolactinomas, Cushing's disease and Nelson's syndrome. Endokrynol Pol (1986) 0.75
[Effect of synthetic LH-RH on the secretion of LM, FSH and testosterone in Stain-Leventhal syndrome]. Endokrynol Pol (1978) 0.75
The circadian rhythm of melatonin in hypothyroidism and hyperthyroidism. Acta Endocrinol (Copenh) (1988) 0.75
[Diurnal rhythm of prolactin secretion after excessive intake of alcohol]. Endokrynol Pol (1984) 0.75
Polycystic ovary syndrome, accompanied by autonomous prolactin hypersecretion. Case report. Ginekol Pol (1982) 0.75
Methodologic basis for the radioimmunoassay of endogenous LH-like activity in human prostatic tissue. Nuklearmedizin (1983) 0.75
[Antidiuretic action of chlorpropamide in diabetes insipidus caused by vasopressin deficiency]. Pol Arch Med Wewn (1972) 0.75
[Excessive secretion of antidiuretic hormone (Schwartz-Bartter syndrome)]. Pol Arch Med Wewn (1971) 0.75
Mixed pituitary tumours--effects of bromocriptine treatment: Parlodel MR and Parlodel LAR. Endokrynol Pol (1992) 0.75
[Diurnal rhythm of thyrotropin secretion in healthy women and in patients with primary hypothyroidism]. Endokrynol Pol (1983) 0.75
[Diurnal rhythm of prolactin secretion in women with primary hypothyroidism]. Endokrynol Pol (1984) 0.75
Growth hormone (GH) secretion during nocturnal sleep and after clonidine in patients with essential hypertension. Clin Exp Hypertens A (1988) 0.75
Thyrotropin-releasing hormone (TRH) does not suppress growth hormone response to L-dopa in insulin-dependent diabetes mellitus. Endokrynol Pol (1992) 0.75
[Scintigraphic and clinical evaluation of the surgical treatment of latent differentiated cancer of the thyroid]. Pol Tyg Lek (1982) 0.75
[Effect of endogenous glucocorticosteroids on TRH-induced TSH secretion]. Endokrynol Pol (1978) 0.75
Lower 24-hour growth hormone levels in type I diabetics responding to thyrotropin-releasing hormone (TRH). Endokrynol Pol (1992) 0.75
Clinical applications of radioimmunoassay of the alpha-subunit of glycoprotein hormones. Endokrynol Pol (1992) 0.75
[Studies on the pathogenesis of arterial hypertension in acromegaly. II. Disorders of prolactin secretion]. Pol Arch Med Wewn (1983) 0.75
[Effect of synthetic LH-RH on gonadotropin secretion: LH and FSH in women with Addison's disease]. Endokrynol Pol (1980) 0.75
[Inhibition of growth hormone (GH) response to GHRH in diabetes mellitus type 1 after blockade of the cholinergic system with pirenzepine]. Pol Arch Med Wewn (1992) 0.75
[Ectopic production of parathyroid hormone (PTH) by malignant tumors]. Endokrynol Pol (1982) 0.75
[Dissociation of the renin-angiotensin-aldosterone system in hyperthyroidism]. Pol Tyg Lek (1985) 0.75
New long-acting bromocriptine (Parlodel MR and Parlodel LAR) in the treatment of pituitary tumours with hyperprolactinemia. Endokrynol Pol (1992) 0.75
[Pulmonary infarction and pulmonary artery embolism]. Pol Tyg Lek (1966) 0.75
Growth hormone response to a low dose dopamine infusion in type I diabetics. Endokrynol Pol (1988) 0.75
Effect of insulin-induced hypoglycemia on plasma renin activity and aldosterone and cortisol concentration in humans. Endokrynol Pol (1986) 0.75
[Results of treatment of hirsutism with spironolactone]. Endokrynol Pol (1982) 0.75
Plasma concentrations of atrial natriuretic hormone in acromegaly: relationship to hypertension. Acta Endocrinol (Copenh) (1991) 0.75
[Effect of hypercalcemia on the secretion of insulin and anterior pituitary hormones]. Endokrynol Pol (1984) 0.75
Prostatectomy--induced decrease in an enhanced serum testosterone concentration in patients with prostatic hyperplasia and its pathophysiological implications. Endokrynol Pol (1979) 0.75
[Prolactin secretion in patients with hyperthyroidism]. Pol Tyg Lek (1985) 0.75
[Thyroid function in patients with decompensated liver cirrhosis]. Endokrynol Pol (1982) 0.75
Increased activity of digoxin-like substance in low-renin hypertension in acromegaly. Clin Exp Hypertens A (1990) 0.75
[Ocular hypertension in patients with infiltrative-edematous exophthalmos in Graves' disease]. Klin Oczna (1990) 0.75
[Different hypogonadism mechanism in men and women suffering from Cushing's disease]. Endokrynol Pol (1981) 0.75
[Attempt at diagnosis of pituitary microadenomas as a cause of spontaneous hyperprolactinemia]. Endokrynol Pol (1981) 0.75
[State of radiological diagnosis. I. Organization problems]. Pol Przegl Radiol Med Nukl (1974) 0.75
[Relationship between clinical classification of hyperthyroidism for three grades of severity and level of triiodothyronine (T3) and thyroxine (T4) concentrations in serum]. Endokrynol Pol (1992) 0.75
High blood pressure and hyperinsulinaemia in acromegaly and in obesity. Clin Exp Hypertens A (1989) 0.75
[Physiological rhythm of triiodothyronine secretion]. Endokrynol Pol (1979) 0.75
[Bronchogenic carcinoma associated with endocrine disorders]. Pol Tyg Lek (1972) 0.75
[Hyperaldosteronism after metoclopramide administration]. Pol Arch Med Wewn (1980) 0.75
[Hypothyroidism and pregnancy]. Pol Tyg Lek (1986) 0.75
[Assessment of the function of the hypothalamo-hypophyseal axis in patients with uncontrolled liver cirrhosis. I. Effect of exogenous thyreoliberin (TRH)]. Pol Arch Med Wewn (1982) 0.75
[Sex hormones in men with coronary arteriosclerosis]. Pol Tyg Lek (1991) 0.75
Decreased melatonin concentration in Cushing's syndrome. Horm Metab Res (1989) 0.75
Effects of transdermal 17 beta-oestradiol combined with oral progestogen on lipids and lipoproteins in hypercholesterolaemic postmenopausal women. J Intern Med (1993) 0.75
[Effect of calcitonin on the secretion of PRL, TSH, GH, LH, FSH, cortisol, T3 and T4]. Endokrynol Pol (1984) 0.75
[Alcohol decreases the alpha subunit, LH and testosterone secretion in response to LH-RH]. Endokrynol Pol (1992) 0.75
[Increased reverse triiodothyronine concentration in anorexia nervosa]. Endokrynol Pol (1981) 0.75
[Prolactin secretion in pituitary tumors and in galactorrhea syndrome]. Endokrynol Pol (1979) 0.75
The effect of D-Trp6-LRH upon secretion of gonadotrophin--a possible therapeutic application in anorexia nervosa. Acta Endocrinol (Copenh) (1984) 0.75
[Ocular hydrodynamics in patients with infiltrative-edematous exophthalmos in Graves' disease]. Klin Oczna (1990) 0.75
[Studies on the pathogenesis of arterial hypertension in acromegaly. I. The renin-angiotensin-aldosterone system]. Pol Arch Med Wewn (1983) 0.75
[Analysis of calcitonin level in the diagnosis and evaluation of the results of the treatment of medullary carcinoma of the thyroid gland]. Pol Tyg Lek (1990) 0.75
[Postprandial determination of growth hormone (GH) in the serum in response to TRH. A new test in the diagnosis of active acromegaly and gigantism]. Pol Arch Med Wewn (1979) 0.75